MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617064848 A) filed by Daewoong Pharmaceutical Co. , Ltd. on May 22, 2026, for Novel Heterocyclic Compounds And Pharmaceutical Composition Comprising The Same As Dna Polymerase Theta Inhibitors For The Prevention Or Treatment Of Cancer.
Inventors include Cao, Bin; Tian, Ye; Qin, Li Number; Jiang, Yan; Zhao, Liyu; and Dou, Guosheng.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present disclosure relates to a novel heterocyclic compound represented by the Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of cancer.
Disclaimer: Curated by HT Syndication.
